R & D Genetic Testing Overview

GenomixLab+Helix

GenomixLAB® combines Next Generation Sequencing (NGS) with the latest analytical procedures and bioinformatics to improve and develop various genetic testing services we offer.

The current product under R&D is Noninvasive Prenatal Testing for Thalassaemia. This procedure will help screen the foetus for thalassaemia using the mother’s blood sample, minimising the risk associated with invasive procedures like amniocentesis. Since β-Thalassemia is the most common autosomal recessive single-gene disorder in Malaysia, we anticipate that this product will benefit many thalassaemia carrier couples.

Service Workflow